Cabot Corporation (NYSE:CBT) Receives Average Rating of “Hold” from Analysts

Shares of Cabot Corporation (NYSE:CBT) have earned an average recommendation of “Hold” from the six brokerages that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $72.25.

CBT has been the topic of a number of research analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and set a $81.00 target price on shares of Cabot in a report on Thursday, January 8th. JPMorgan Chase & Co. reduced their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. Mizuho boosted their target price on shares of Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Finally, Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday.

Cabot Trading Up 1.1%

Cabot stock opened at $72.28 on Friday. Cabot has a 12-month low of $58.33 and a 12-month high of $89.16. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.61 and a quick ratio of 1.08. The stock has a market capitalization of $3.82 billion, a PE ratio of 12.03, a price-to-earnings-growth ratio of 3.74 and a beta of 0.89. The firm has a 50 day simple moving average of $67.93 and a 200-day simple moving average of $71.76.

Cabot (NYSE:CBT) last released its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The firm had revenue of $899.00 million during the quarter, compared to analyst estimates of $967.02 million. Cabot had a return on equity of 24.55% and a net margin of 8.91%.The business’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same quarter last year, the company earned $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities research analysts expect that Cabot will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.5%. Cabot’s payout ratio is 29.95%.

Hedge Funds Weigh In On Cabot

A number of institutional investors have recently bought and sold shares of CBT. Comerica Bank lifted its stake in Cabot by 33.0% during the fourth quarter. Comerica Bank now owns 43,025 shares of the specialty chemicals company’s stock valued at $2,852,000 after buying an additional 10,686 shares in the last quarter. Pictet Asset Management Holding SA lifted its position in shares of Cabot by 10.5% in the 4th quarter. Pictet Asset Management Holding SA now owns 8,518 shares of the specialty chemicals company’s stock valued at $565,000 after acquiring an additional 811 shares in the last quarter. UBS Group AG boosted its stake in Cabot by 3.5% in the 4th quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock worth $40,708,000 after purchasing an additional 20,668 shares during the period. Peregrine Capital Management LLC grew its position in Cabot by 24.7% during the 4th quarter. Peregrine Capital Management LLC now owns 79,148 shares of the specialty chemicals company’s stock worth $5,246,000 after purchasing an additional 15,669 shares in the last quarter. Finally, M&T Bank Corp grew its position in Cabot by 57.0% during the 4th quarter. M&T Bank Corp now owns 25,764 shares of the specialty chemicals company’s stock worth $1,708,000 after purchasing an additional 9,351 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.